The Claude D. Pepper Older Americans Independence Centers Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2021
NCT04482712
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

The Claude D. Pepper Older Americans Independence Centers

Active Ingredients

Drugs in Phase 4 Trials (2)

denosumab (prolia) (1 trial)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 2 Trials (1)

sirolimus (rapamune) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 2)

Lung Injury (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Respiratory Insufficiency (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3